(+)-Tetrandrine increases expression ISO RGD:1353398 6480464 tetrandrine results in increased expression of ATG5 protein CTD PMID:26822499 (+)-Tetrandrine decreases expression ISO RGD:1353398 6480464 tetrandrine results in decreased expression of ATG5 protein CTD PMID:25266202 (-)-citrinin increases expression ISO RGD:1556965 6480464 Citrinin results in increased expression of ATG5 mRNA CTD PMID:22771370 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1353398 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATG5 mRNA CTD PMID:22079256 1,2-dimethylhydrazine multiple interactions ISO RGD:1556965 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATG5 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1556965 6480464 1, 2-Dimethylhydrazine results in decreased expression of ATG5 mRNA CTD PMID:22206623 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1556965 6480464 Tetrachlorodibenzodioxin affects the expression of ATG5 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ATG5 mRNA CTD PMID:33387578 2-(tert-butylimino)-5-phenyl-3-(propan-2-yl)-1,3,5-thiadiazinan-4-one increases expression ISO RGD:1353398 6480464 buprofezin results in increased expression of ATG5 mRNA CTD PMID:36287832 2-hydroxyethyl methacrylate multiple interactions ISO RGD:1353398 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased expression of ATG5 protein] more ... CTD PMID:28184909 2-hydroxyethyl methacrylate increases expression ISO RGD:1353398 6480464 hydroxyethyl methacrylate results in increased expression of ATG5 protein CTD PMID:28184909 2-hydroxypropanoic acid decreases expression ISO RGD:1353398 6480464 Lactic Acid results in decreased expression of ATG5 mRNA CTD PMID:30851411 3,3',5-triiodo-L-thyronine increases expression ISO RGD:1556965 6480464 Triiodothyronine results in increased expression of ATG5 mRNA, Triiodothyronine results in increased expression of ATG5 protein CTD PMID:30209975 3,3',5-triiodo-L-thyronine affects response to substance ISO RGD:1556965 6480464 ATG5 protein affects the susceptibility to Triiodothyronine CTD PMID:30209975 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of ATG5 protein CTD PMID:34915118 3-hydroxybutyric acid increases abundance ISO RGD:1353398 6480464 ATG5 protein results in increased abundance of 3-Hydroxybutyric Acid CTD PMID:25943029 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1353398 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATG5 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATG5 mRNA CTD PMID:28628672 3-methyladenine multiple interactions ISO RGD:1353398 6480464 3-methyladenine inhibits the reaction [hydroxyethyl methacrylate results in increased expression of ATG5 protein] more ... CTD PMID:18818525 more ... 3-methyladenine increases expression ISO RGD:1353398 6480464 3-methyladenine results in increased expression of ATG5 protein CTD PMID:32587277 3-methyladenine decreases expression ISO RGD:1353398 6480464 3-methyladenine results in decreased expression of ATG5 protein CTD PMID:29781141 3-methyladenine multiple interactions ISO RGD:1556965 6480464 3-methyladenine affects the reaction [T-2 Toxin affects the expression of ATG5 protein], 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] CTD PMID:33462182 , PMID:36402210 3-methyladenine decreases expression EXP 6480464 3-methyladenine results in decreased expression of ATG5 mRNA, 3-methyladenine results in decreased expression of ATG5 protein CTD PMID:30611790 3-methyladenine multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [aristolochic acid I results in increased expression of ATG5 protein] more ... CTD PMID:23939141 , PMID:29128638 4'-epidoxorubicin decreases expression EXP 6480464 Epirubicin results in decreased expression of ATG5 protein CTD PMID:29505745 4'-epidoxorubicin multiple interactions EXP 6480464 paeonol inhibits the reaction [Epirubicin results in decreased expression of ATG5 protein], Sirolimus inhibits the reaction [Epirubicin results in decreased expression of ATG5 protein] CTD PMID:29505745 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1353398 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATG5 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases expression ISO RGD:1556965 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of ATG5 mRNA CTD PMID:29741722 4-hydroxynon-2-enal increases expression ISO RGD:1353398 6480464 4-hydroxy-2-nonenal results in increased expression of ATG5 mRNA CTD PMID:35550146 4-nonylphenol increases expression EXP 6480464 4-nonylphenol results in increased expression of ATG5 mRNA CTD PMID:28041982 , PMID:30228064 4-phenylbutyric acid multiple interactions ISO RGD:1556965 6480464 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 mRNA], 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 protein] CTD PMID:34175825 5-aza-2'-deoxycytidine decreases expression EXP 6480464 Decitabine results in decreased expression of ATG5 protein CTD PMID:34536542 acrolein multiple interactions ISO RGD:1353398 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATG5 mRNA more ... CTD PMID:30205151 , PMID:32699268 acrolein increases expression ISO RGD:1353398 6480464 Acrolein results in increased expression of ATG5 protein CTD PMID:30205151 acrylamide increases expression ISO RGD:1353398 6480464 Acrylamide results in increased expression of ATG5 mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:1353398 6480464 Aflatoxin B1 results in decreased expression of ATG5 mRNA CTD PMID:21641981 AICA ribonucleotide multiple interactions ISO RGD:1353398 6480464 AICA ribonucleotide inhibits the reaction [Ethanol results in decreased expression of ATG5 protein] CTD PMID:24582693 aldehydo-D-glucose multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of ATG5 protein CTD PMID:29128638 all-trans-retinoic acid increases expression ISO RGD:1353398 6480464 Tretinoin results in increased expression of ATG5 mRNA, Tretinoin results in increased expression of ATG5 protein CTD PMID:29743969 all-trans-retinoic acid multiple interactions ISO RGD:1353398 6480464 ATG5 protein affects the reaction [Tretinoin results in increased metabolism of and affects the localization of MAP1LC3B protein] more ... CTD PMID:28978663 , PMID:29743969 alpha,alpha-trehalose increases expression ISO RGD:1556965 6480464 Trehalose results in increased expression of ATG5 mRNA CTD PMID:23851366 alpha-D-galactose multiple interactions EXP 6480464 candesartan inhibits the reaction [Galactose results in decreased expression of ATG5 mRNA] CTD PMID:34906534 alpha-D-galactose decreases expression EXP 6480464 Galactose results in decreased expression of ATG5 mRNA CTD PMID:34906534 alpha-pinene multiple interactions ISO RGD:1353398 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATG5 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ATG5 mRNA CTD PMID:32699268 amiodarone affects response to substance ISO RGD:1353398 6480464 ATG5 protein affects the susceptibility to Amiodarone CTD PMID:32651653 antirheumatic drug increases expression ISO RGD:1353398 6480464 Antirheumatic Agents results in increased expression of ATG5 mRNA CTD PMID:24449571 aristolochic acid A multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [aristolochic acid I results in increased expression of ATG5 protein], ATG5 affects the reaction [aristolochic acid I results in increased cleavage of PARP1 protein] CTD PMID:23939141 aristolochic acid A decreases expression ISO RGD:1353398 6480464 aristolochic acid I results in decreased expression of ATG5 mRNA CTD PMID:33212167 aristolochic acid A increases response to substance EXP 6480464 ATG5 results in increased susceptibility to aristolochic acid I CTD PMID:23939141 aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of ATG5 protein CTD PMID:23939141 arsenite(3-) increases expression ISO RGD:1353398 6480464 arsenite results in increased expression of ATG5 mRNA, arsenite results in increased expression of ATG5 protein CTD PMID:34929507 arsenous acid increases expression ISO RGD:1353398 6480464 Arsenic Trioxide results in increased expression of ATG5 mRNA, Arsenic Trioxide results in increased expression of ATG5 protein CTD PMID:21594580 more ... arsenous acid multiple interactions EXP 6480464 ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in decreased expression of ATG5 protein] CTD PMID:35195477 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of ATG5 protein CTD PMID:35195477 arsenous acid multiple interactions ISO RGD:1556965 6480464 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA], Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] CTD PMID:33462182 arsenous acid increases expression ISO RGD:1556965 6480464 Arsenic Trioxide results in increased expression of ATG5 mRNA CTD PMID:30032600 more ... arsenous acid multiple interactions ISO RGD:1353398 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] more ... CTD PMID:28978663 more ... artesunate increases expression ISO RGD:1353398 6480464 Artesunate results in increased expression of ATG5 mRNA CTD PMID:30551460 atorvastatin calcium multiple interactions ISO RGD:1556965 6480464 ATG5 mutant form promotes the reaction [Atorvastatin results in increased cleavage of CASP3 protein], ATG5 mutant form promotes the reaction [Atorvastatin results in increased cleavage of PARP1 protein] CTD PMID:20876807 atorvastatin calcium increases response to substance ISO RGD:1556965 6480464 ATG5 results in increased susceptibility to Atorvastatin CTD PMID:20876807 atrazine increases expression ISO RGD:1556965 6480464 Atrazine results in increased expression of ATG5 mRNA, Atrazine results in increased expression of ATG5 protein CTD PMID:33485040 atrazine decreases expression ISO RGD:1556965 6480464 Atrazine results in decreased expression of ATG5 mRNA CTD PMID:30360616 atrazine multiple interactions ISO RGD:1556965 6480464 Lycopene inhibits the reaction [Atrazine results in decreased expression of ATG5 mRNA] CTD PMID:30360616 bafilomycin A1 multiple interactions ISO RGD:1353398 6480464 ATG5 protein affects the reaction [bafilomycin A1 promotes the reaction [gossypol acetic acid results in increased expression of MAP1LC3B protein modified form]] CTD PMID:29938581 bafilomycin A1 multiple interactions ISO RGD:1556965 6480464 [bafilomycin A1 co-treated with Swainsonine] results in increased expression of ATG5 mRNA, [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of ATG5 protein CTD PMID:36402259 benzo[a]pyrene increases methylation ISO RGD:1353398 6480464 Benzo(a)pyrene results in increased methylation of ATG5 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1353398 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 bisphenol A decreases expression ISO RGD:1353398 6480464 bisphenol A results in decreased expression of ATG5 mRNA CTD PMID:20678512 bisphenol A increases expression ISO RGD:1556965 6480464 bisphenol A results in increased expression of ATG5 mRNA CTD PMID:34281243 bisphenol A decreases expression ISO RGD:1556965 6480464 bisphenol A results in decreased expression of ATG5 mRNA CTD PMID:29741722 bisphenol A multiple interactions ISO RGD:1353398 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATG5 mRNA CTD PMID:28628672 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ATG5 mRNA CTD PMID:27539358 , PMID:30228064 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ATG5 mRNA CTD PMID:25181051 bortezomib multiple interactions ISO RGD:1556965 6480464 ATG5 gene mutant form inhibits the reaction [Bortezomib results in increased cleavage of and results in increased activity of CASP3 protein], ATG5 gene mutant form inhibits the reaction [HRAS protein promotes the reaction [Bortezomib results in increased cleavage of and results in increased activity of CASP3 protein]] CTD PMID:22842577 buprofezin increases expression ISO RGD:1353398 6480464 buprofezin results in increased expression of ATG5 mRNA CTD PMID:36287832 butachlor increases expression ISO RGD:1556965 6480464 butachlor results in increased expression of ATG5 protein CTD PMID:34351278 butachlor decreases expression ISO RGD:1556965 6480464 butachlor results in decreased expression of ATG5 mRNA CTD PMID:34351278 butyric acid increases expression ISO RGD:1353398 6480464 Butyric Acid results in increased expression of ATG5 protein CTD PMID:28600122 butyric acid multiple interactions ISO RGD:1353398 6480464 Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of ATG5 protein] CTD PMID:28600122 cadmium atom increases expression ISO RGD:1556965 6480464 Cadmium results in increased expression of ATG5 mRNA CTD PMID:27492225 cadmium atom multiple interactions ISO RGD:1353398 6480464 ATG5 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SQSTM1 protein], ATG5 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MTOR protein] CTD PMID:36336208 cadmium atom multiple interactions ISO RGD:1556965 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG5 protein more ... CTD PMID:29111403 , PMID:31862506 cadmium atom multiple interactions EXP 6480464 ATG5 protein affects the reaction [Cadmium results in decreased expression of SQSTM1 protein] more ... CTD PMID:27658547 cadmium dichloride multiple interactions ISO RGD:1556965 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG5 protein CTD PMID:31862506 cadmium dichloride multiple interactions ISO RGD:1353398 6480464 ATG5 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SQSTM1 protein], ATG5 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MTOR protein] CTD PMID:36336208 cadmium dichloride increases expression ISO RGD:1353398 6480464 Cadmium Chloride results in increased expression of ATG5 protein CTD PMID:33127495 calcitriol increases response to substance ISO RGD:1353398 6480464 ATG5 results in increased susceptibility to Calcitriol CTD PMID:19748465 calcitriol multiple interactions ISO RGD:1353398 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in increased activity of ATG5 mRNA] more ... CTD PMID:19748465 calcitriol increases expression ISO RGD:1353398 6480464 Calcitriol results in increased expression of ATG5 mRNA CTD PMID:19748465 camptothecin multiple interactions ISO RGD:1353398 6480464 ATG5 mutant form inhibits the reaction [Camptothecin results in increased degradation of SQSTM1 protein] CTD PMID:22927544 candesartan multiple interactions EXP 6480464 candesartan inhibits the reaction [Galactose results in decreased expression of ATG5 mRNA] CTD PMID:34906534 capsaicin multiple interactions ISO RGD:1353398 6480464 ATG5 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of ATM protein], ATG5 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of PRKDC protein] CTD PMID:22226932 capsaicin increases expression ISO RGD:1353398 6480464 Capsaicin results in increased expression of ATG5 protein CTD PMID:22226932 carbamazepine multiple interactions EXP 6480464 [[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of ATG5 mRNA, [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of ATG5 mRNA CTD PMID:35786680 carbon disulfide decreases expression ISO RGD:1556965 6480464 Carbon Disulfide results in decreased expression of ATG5 mRNA, Carbon Disulfide results in decreased expression of ATG5 protein CTD PMID:31369747 carbon disulfide multiple interactions ISO RGD:1556965 6480464 N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of ATG5 mRNA] CTD PMID:31369747 carbon nanotube increases expression ISO RGD:1556965 6480464 Nanotubes, Carbon results in increased expression of ATG5 protein CTD PMID:24929217 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of ATG5 mRNA CTD PMID:32951350 carglumic acid multiple interactions ISO RGD:1556965 6480464 N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of ATG5 mRNA] CTD PMID:31369747 CGP 52608 multiple interactions ISO RGD:1353398 6480464 CGP 52608 promotes the reaction [RORA protein binds to ATG5 gene] CTD PMID:28238834 chloroquine multiple interactions ISO RGD:1353398 6480464 Chloroquine inhibits the reaction [hydroxyethyl methacrylate results in increased expression of ATG5 protein], Chloroquine promotes the reaction [Arsenic Trioxide results in increased expression of ATG5 protein] CTD PMID:28184909 , PMID:30338810 chloroquine increases expression ISO RGD:1353398 6480464 Chloroquine results in increased expression of ATG5 protein CTD PMID:30338810 chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [cadmium acetate results in increased expression of ATG5 protein] CTD PMID:29870746 chromium(6+) multiple interactions EXP 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ATG5 protein CTD PMID:36849043 cisplatin multiple interactions ISO RGD:1353398 6480464 [Cisplatin co-treated with acetyl-11-ketoboswellic acid] results in decreased expression of ATG5 protein more ... CTD PMID:21743489 more ... cisplatin multiple interactions ISO RGD:1556965 6480464 Oleanolic Acid inhibits the reaction [Cisplatin results in increased expression of ATG5 protein] CTD PMID:31306688 cisplatin increases expression ISO RGD:1556965 6480464 Cisplatin results in increased expression of ATG5 protein CTD PMID:31306688 cisplatin decreases expression ISO RGD:1353398 6480464 Cisplatin results in decreased expression of ATG5 protein CTD PMID:28408137 cisplatin increases expression ISO RGD:1353398 6480464 Cisplatin results in increased expression of ATG5 protein CTD PMID:24817946 cisplatin decreases response to substance ISO RGD:1353398 6480464 ATG5 protein results in decreased susceptibility to Cisplatin CTD PMID:21351258 colistin increases expression ISO RGD:1556965 6480464 Colistin results in increased expression of ATG5 mRNA CTD PMID:35378205 copper atom multiple interactions ISO RGD:1556965 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 mRNA, [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 protein CTD PMID:31491480 copper(0) multiple interactions ISO RGD:1556965 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 mRNA, [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 protein CTD PMID:31491480 copper(II) sulfate multiple interactions ISO RGD:1556965 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 mRNA, [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 protein CTD PMID:31491480 curcumin decreases expression ISO RGD:1353398 6480464 Curcumin results in decreased expression of ATG5 protein CTD PMID:36640941 curcumin decreases expression ISO RGD:1556965 6480464 Curcumin results in decreased expression of ATG5 protein CTD PMID:36640941 curcumin multiple interactions ISO RGD:1353398 6480464 Curcumin inhibits the reaction [Tunicamycin results in increased expression of ATG5 protein] CTD PMID:36640941 Curcumol multiple interactions EXP 6480464 [ATG5 protein co-treated with curcumol] inhibits the reaction [VEGFA protein results in increased expression of ANGPT2 protein] more ... CTD PMID:33549628 Curcumol multiple interactions ISO RGD:1556965 6480464 ATG5 protein inhibits the reaction [curcumol inhibits the reaction [Carbon Tetrachloride results in increased activity of GPT protein]] more ... CTD PMID:33549628 cyclophosphamide multiple interactions ISO RGD:1556965 6480464 Fungal Polysaccharides inhibits the reaction [Cyclophosphamide results in decreased expression of ATG5 protein], Levamisole inhibits the reaction [Cyclophosphamide results in decreased expression of ATG5 protein] CTD PMID:32151603 cyclophosphamide decreases expression ISO RGD:1556965 6480464 Cyclophosphamide results in decreased expression of ATG5 protein CTD PMID:32151603 cyclosporin A increases expression ISO RGD:1353398 6480464 Cyclosporine results in increased expression of ATG5 mRNA CTD PMID:25562108 cypermethrin increases expression ISO RGD:1353398 6480464 cypermethrin results in increased expression of ATG5 mRNA CTD PMID:27704156 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of ATG5 protein CTD PMID:29128638 D-glucose multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 dexamethasone multiple interactions ISO RGD:1353398 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATG5 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATG5 mRNA CTD PMID:28628672 dextran sulfate multiple interactions ISO RGD:1556965 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]] more ... CTD PMID:27611972 more ... dextran sulfate increases expression ISO RGD:1556965 6480464 Dextran Sulfate results in increased expression of ATG5 mRNA CTD PMID:31676321 diarsenic trioxide increases expression ISO RGD:1353398 6480464 Arsenic Trioxide results in increased expression of ATG5 mRNA, Arsenic Trioxide results in increased expression of ATG5 protein CTD PMID:21594580 more ... diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of ATG5 protein CTD PMID:35195477 diarsenic trioxide multiple interactions EXP 6480464 ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in decreased expression of ATG5 protein] CTD PMID:35195477 diarsenic trioxide multiple interactions ISO RGD:1556965 6480464 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA], Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] CTD PMID:33462182 diarsenic trioxide increases expression ISO RGD:1556965 6480464 Arsenic Trioxide results in increased expression of ATG5 mRNA CTD PMID:30032600 more ... diarsenic trioxide multiple interactions ISO RGD:1353398 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] more ... CTD PMID:28978663 more ... dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of ATG5 mRNA CTD PMID:30053495 dicrotophos decreases expression ISO RGD:1353398 6480464 dicrotophos results in decreased expression of ATG5 mRNA CTD PMID:28302478 diphenhydramine affects response to substance ISO RGD:1556965 6480464 ATG5 protein affects the susceptibility to Diphenhydramine CTD PMID:22310178 disodium selenite increases expression ISO RGD:1353398 6480464 Sodium Selenite results in increased expression of ATG5 protein CTD PMID:25204997 Doramectin increases expression EXP 6480464 doramectin results in increased expression of ATG5 protein CTD PMID:35137919 Doramectin increases expression ISO RGD:1353398 6480464 doramectin results in increased expression of ATG5 protein CTD PMID:35137919 doxorubicin multiple interactions EXP 6480464 [4-(((4-carboxybutyl) (2- (5-fluoro-2-((4'-(trifluoromethyl) biphenyl-4-yl)methoxy)phenyl)ethyl) amino)methyl)benzoic acid co-treated with Doxorubicin] results in increased expression of ATG5 protein more ... CTD PMID:32652078 more ... doxorubicin increases expression ISO RGD:1556965 6480464 Doxorubicin results in increased expression of ATG5 protein CTD PMID:36639017 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of ATG5 protein CTD PMID:36639017 doxorubicin multiple interactions ISO RGD:1556965 6480464 OTUD7B protein inhibits the reaction [Doxorubicin results in increased expression of ATG5 protein], Sirolimus inhibits the reaction [OTUD7B protein inhibits the reaction [Doxorubicin results in increased expression of ATG5 protein]] CTD PMID:36639017 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of ATG5 mRNA CTD PMID:34933056 doxorubicin decreases expression ISO RGD:1353398 6480464 Doxorubicin results in decreased expression of ATG5 mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:1353398 6480464 Doxorubicin results in increased expression of ATG5 protein CTD PMID:31226464 doxorubicin multiple interactions ISO RGD:1353398 6480464 PQQ Cofactor inhibits the reaction [Doxorubicin results in increased expression of ATG5 protein] CTD PMID:31226464 ellagic acid increases expression ISO RGD:1353398 6480464 Ellagic Acid results in increased expression of ATG5 mRNA CTD PMID:12002526 embelin multiple interactions ISO RGD:1353398 6480464 embelin results in increased cleavage of [ATG12 protein binds to ATG5 protein] CTD PMID:28722333 erastin increases expression EXP 6480464 erastin results in increased expression of ATG5 protein CTD PMID:32937103 erlotinib hydrochloride decreases response to substance ISO RGD:1353398 6480464 ATG5 protein results in decreased susceptibility to Erlotinib Hydrochloride CTD PMID:23917044 erlotinib hydrochloride increases expression ISO RGD:1353398 6480464 Erlotinib Hydrochloride results in increased expression of ATG5 protein CTD PMID:21655094 ethanol multiple interactions ISO RGD:1556965 6480464 NR1H4 gene mutant form inhibits the reaction [Ethanol results in increased expression of ATG5 mRNA] more ... CTD PMID:24095927 more ... ethanol decreases expression ISO RGD:1556965 6480464 Ethanol results in decreased expression of ATG5 protein CTD PMID:34405320 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of ATG5 protein CTD PMID:24582693 ethanol multiple interactions EXP 6480464 ADIPOQ protein inhibits the reaction [Ethanol results in decreased expression of ATG5 protein] CTD PMID:24582693 ethanol decreases expression ISO RGD:1353398 6480464 Ethanol results in decreased expression of ATG5 mRNA, Ethanol results in decreased expression of ATG5 protein CTD PMID:24582693 , PMID:34405320 ethanol multiple interactions ISO RGD:1353398 6480464 ADIPOQ protein inhibits the reaction [Ethanol results in decreased expression of ATG5 mRNA] more ... CTD PMID:24582693 , PMID:34405320 ethanol decreases response to substance ISO RGD:1353398 6480464 ATG5 protein results in decreased susceptibility to Ethanol CTD PMID:24582693 ethanol increases expression ISO RGD:1556965 6480464 Ethanol results in increased expression of ATG5 mRNA, Ethanol results in increased expression of ATG5 protein CTD PMID:24095927 more ... ethanol increases expression ISO RGD:1353398 6480464 Ethanol results in increased expression of ATG5 mRNA CTD PMID:24095927 ferric oxide increases expression ISO RGD:1556965 6480464 ferric oxide analog results in increased expression of ATG5 protein CTD PMID:24068039 ferrostatin-1 multiple interactions EXP 6480464 ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in decreased expression of ATG5 protein] CTD PMID:35195477 fingolimod hydrochloride increases expression ISO RGD:1353398 6480464 Fingolimod Hydrochloride results in increased expression of ATG5 protein CTD PMID:25939952 flavokawain B affects response to substance ISO RGD:1353398 6480464 ATG5 protein affects the susceptibility to flavokawain B CTD PMID:30025493 flavokawain B multiple interactions ISO RGD:1353398 6480464 [ATG5 protein affects the susceptibility to flavokawain B] which affects the cleavage of CASP3 protein more ... CTD PMID:30025493 flutamide increases expression EXP 6480464 Flutamide results in increased expression of ATG5 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1556965 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATG5 mRNA CTD PMID:22206623 Fusaric acid increases expression ISO RGD:1353398 6480464 Fusaric Acid results in increased expression of ATG5 mRNA CTD PMID:30582969 galactose multiple interactions EXP 6480464 candesartan inhibits the reaction [Galactose results in decreased expression of ATG5 mRNA] CTD PMID:34906534 galactose decreases expression EXP 6480464 Galactose results in decreased expression of ATG5 mRNA CTD PMID:34906534 gefitinib increases expression ISO RGD:1353398 6480464 gefitinib results in increased expression of ATG5 protein CTD PMID:21655094 genistein increases expression ISO RGD:1353398 6480464 Genistein results in increased expression of ATG5 mRNA CTD PMID:15256057 geraniol multiple interactions ISO RGD:1353398 6480464 geraniol inhibits the reaction [Rotenone results in decreased expression of ATG5 protein] CTD PMID:30141137 glucose multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 glucose decreases expression EXP 6480464 Glucose results in decreased expression of ATG5 protein CTD PMID:29128638 glutathione affects abundance ISO RGD:1556965 6480464 ATG5 protein affects the abundance of Glutathione CTD PMID:22491424 glutathione multiple interactions ISO RGD:1556965 6480464 [ATG5 gene mutant form results in increased activity of NFE2L2 protein] affects the reaction [Acetaminophen affects the abundance of Glutathione] more ... CTD PMID:22491424 glycochenodeoxycholic acid multiple interactions ISO RGD:1353398 6480464 TFE3 protein inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of ATG5 mRNA] CTD PMID:32439580 glycochenodeoxycholic acid decreases expression ISO RGD:1353398 6480464 Glycochenodeoxycholic Acid results in decreased expression of ATG5 mRNA, Glycochenodeoxycholic Acid results in decreased expression of ATG5 protein CTD PMID:32439580 glyphosate increases expression ISO RGD:1353398 6480464 glyphosate results in increased expression of ATG5 mRNA CTD PMID:31874349 gossypetin multiple interactions ISO RGD:1353398 6480464 gossypetin promotes the reaction [malondialdehyde-low density lipoprotein, human promotes the reaction [ATG5 protein binds to ATG12 protein]] CTD PMID:25622137 hesperetin multiple interactions EXP 6480464 hesperetin inhibits the reaction [Doxorubicin results in decreased expression of ATG5 mRNA] CTD PMID:34933056 hexadecanoic acid multiple interactions ISO RGD:1353398 6480464 ATG5 protein promotes the reaction [resveratrol inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]] CTD PMID:25943029 hexadecanoic acid multiple interactions EXP 6480464 ATG5 protein promotes the reaction [C1QTNF9 protein inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]] CTD PMID:32278738 HU-308 multiple interactions ISO RGD:1556965 6480464 ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]], ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]] CTD PMID:27611972 hyaluronic acid multiple interactions EXP 6480464 roxadustat promotes the reaction [Hyaluronic Acid results in increased cleavage of ATG5 protein] CTD PMID:27082295 hyaluronic acid increases cleavage EXP 6480464 Hyaluronic Acid results in increased cleavage of ATG5 protein CTD PMID:27082295 hydroquinone multiple interactions ISO RGD:1353398 6480464 PARP1 protein promotes the reaction [hydroquinone results in increased expression of ATG5 mRNA], SIRT1 protein inhibits the reaction [hydroquinone results in increased expression of ATG5 mRNA] CTD PMID:28263894 hydroquinone increases expression ISO RGD:1353398 6480464 hydroquinone results in increased expression of ATG5 mRNA CTD PMID:28263894 indometacin multiple interactions ISO RGD:1353398 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATG5 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATG5 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:1353398 6480464 Ivermectin results in decreased expression of ATG5 protein CTD PMID:32959892 kainic acid multiple interactions EXP 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of ATG5 protein] CTD PMID:32057834 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of ATG5 protein CTD PMID:32057834 L-leucine multiple interactions ISO RGD:1556965 6480464 Leucine inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]] CTD PMID:31676321 levamisole multiple interactions ISO RGD:1556965 6480464 Levamisole inhibits the reaction [Cyclophosphamide results in decreased expression of ATG5 protein] CTD PMID:32151603 lipopolysaccharide increases cleavage EXP 6480464 Lipopolysaccharides results in increased cleavage of ATG5 protein CTD PMID:24973090 lipopolysaccharide multiple interactions ISO RGD:1556965 6480464 ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]] more ... CTD PMID:27611972 , PMID:30301768 lipopolysaccharide affects response to substance ISO RGD:1556965 6480464 ATG5 protein affects the susceptibility to Lipopolysaccharides CTD PMID:30301768 lipopolysaccharide multiple interactions EXP 6480464 Sialic Acids inhibits the reaction [Lipopolysaccharides results in increased cleavage of ATG5 protein] CTD PMID:24973090 luteolin increases expression ISO RGD:1353398 6480464 Luteolin results in increased expression of ATG5 protein CTD PMID:32268164 luteolin multiple interactions EXP 6480464 Luteolin inhibits the reaction [Methamphetamine results in increased expression of ATG5 protein] CTD PMID:32035215 LY294002 multiple interactions ISO RGD:1556965 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA]], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA] CTD PMID:35568058 lycopene multiple interactions ISO RGD:1556965 6480464 Lycopene inhibits the reaction [Atrazine results in decreased expression of ATG5 mRNA] CTD PMID:30360616 melatonin multiple interactions ISO RGD:1556965 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA]], Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA] CTD PMID:35568058 menadione affects response to substance EXP 6480464 ATG5 mRNA affects the susceptibility to Vitamin K 3 CTD PMID:20578144 menadione affects response to substance ISO RGD:1556965 6480464 ATG5 protein affects the susceptibility to Vitamin K 3 CTD PMID:18073215 , PMID:18319638 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of ATG5 mRNA, Methamphetamine results in increased expression of ATG5 protein CTD PMID:32035215 more ... methamphetamine increases expression ISO RGD:1556965 6480464 Methamphetamine results in increased expression of ATG5 protein CTD PMID:33359793 methamphetamine multiple interactions EXP 6480464 Luteolin inhibits the reaction [Methamphetamine results in increased expression of ATG5 protein] CTD PMID:32035215 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of ATG5 gene CTD PMID:35440735 methylisothiazolinone increases expression ISO RGD:1353398 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of ATG5 protein CTD PMID:29110394 methylmercury chloride decreases expression ISO RGD:1353398 6480464 methylmercuric chloride results in decreased expression of ATG5 mRNA CTD PMID:23179753 , PMID:27188386 methylmercury chloride multiple interactions ISO RGD:1556965 6480464 ATG5 promotes the reaction [methylmercuric chloride results in increased cleavage of CASP3 protein] more ... CTD PMID:27667695 methylmercury chloride affects response to substance ISO RGD:1556965 6480464 ATG5 affects the susceptibility to methylmercuric chloride CTD PMID:27667695 methylphenidate increases expression EXP 6480464 Methylphenidate results in increased expression of ATG5 mRNA CTD PMID:32746681 microcystin-LR increases expression ISO RGD:1556965 6480464 cyanoginosin LR results in increased expression of ATG5 mRNA, cyanoginosin LR results in increased expression of ATG5 protein CTD PMID:34175825 microcystin-LR multiple interactions ISO RGD:1556965 6480464 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 mRNA], 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 protein] CTD PMID:34175825 N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 N-acetyl-L-cysteine multiple interactions ISO RGD:1353398 6480464 Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG5 protein] more ... CTD PMID:20543569 more ... N-acetyl-L-cysteine multiple interactions ISO RGD:1556965 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA], Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of ATG5 mRNA] CTD PMID:24614525 , PMID:33462182 N-methyl-4-phenylpyridinium affects response to substance ISO RGD:1353398 6480464 ATG5 protein affects the susceptibility to 1-Methyl-4-phenylpyridinium CTD PMID:23997112 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1353398 6480464 ATG5 protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased cleavage of and results in increased activity of CASP3 protein] CTD PMID:23997112 NADP zwitterion multiple interactions EXP 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of ATG5 protein] CTD PMID:32057834 NADP(+) multiple interactions EXP 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of ATG5 protein] CTD PMID:32057834 nickel atom multiple interactions ISO RGD:1353398 6480464 [Nickel co-treated with austenitic steel analog] results in increased expression of ATG5 mRNA CTD PMID:23638002 nickel atom multiple interactions ISO RGD:1556965 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA]] more ... CTD PMID:35568058 nickel atom increases expression ISO RGD:1353398 6480464 Nickel results in increased expression of ATG5 mRNA CTD PMID:25583101 nickel dichloride multiple interactions ISO RGD:1556965 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA]] more ... CTD PMID:35568058 Nonidet P-40 decreases expression ISO RGD:1353398 6480464 Nonidet P-40 results in decreased expression of ATG5 mRNA CTD PMID:26552463 obeticholic acid multiple interactions ISO RGD:1556965 6480464 obeticholic acid inhibits the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in decreased expression of ATG5 mRNA] CTD PMID:35439472 oleanolic acid multiple interactions ISO RGD:1556965 6480464 Oleanolic Acid inhibits the reaction [Cisplatin results in increased expression of ATG5 protein] CTD PMID:31306688 oleanolic acid increases expression ISO RGD:1353398 6480464 Oleanolic Acid analog results in increased expression of ATG5 protein, Oleanolic Acid results in increased expression of ATG5 protein CTD PMID:26612655 , PMID:35690101 oligopeptide increases expression ISO RGD:1353398 6480464 Oligopeptides analog results in increased expression of ATG5 protein CTD PMID:24875536 ozone multiple interactions ISO RGD:1353398 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATG5 mRNA more ... CTD PMID:32699268 p-menthan-3-ol increases expression ISO RGD:1353398 6480464 Menthol results in increased expression of ATG5 mRNA CTD PMID:26760959 Paeonol multiple interactions EXP 6480464 paeonol inhibits the reaction [Epirubicin results in decreased expression of ATG5 protein] CTD PMID:29505745 paracetamol affects expression ISO RGD:1556965 6480464 Acetaminophen affects the expression of ATG5 mRNA CTD PMID:17562736 paracetamol affects response to substance ISO RGD:1556965 6480464 ATG5 protein affects the susceptibility to Acetaminophen CTD PMID:22491424 paracetamol multiple interactions ISO RGD:1556965 6480464 [ATG5 gene mutant form results in increased activity of NFE2L2 protein] affects the reaction [Acetaminophen affects the abundance of Glutathione] more ... CTD PMID:22491424 paraquat affects response to substance ISO RGD:1353398 6480464 ATG5 protein affects the susceptibility to Paraquat CTD PMID:22982048 , PMID:23997112 paraquat affects response to substance ISO RGD:1556965 6480464 ATG5 protein affects the susceptibility to Paraquat CTD PMID:22982048 paraquat affects response to substance EXP 6480464 ATG5 protein affects the susceptibility to Paraquat CTD PMID:27324791 paraquat increases expression ISO RGD:1353398 6480464 Paraquat results in increased expression of ATG5 mRNA CTD PMID:27220436 paraquat multiple interactions ISO RGD:1556965 6480464 [ATG5 protein affects the susceptibility to Paraquat] which affects the abundance of Lipofuscin more ... CTD PMID:22982048 , PMID:27246695 paraquat increases expression ISO RGD:1556965 6480464 Paraquat results in increased expression of ATG5 mRNA, Paraquat results in increased expression of ATG5 protein CTD PMID:22982048 more ... paraquat multiple interactions ISO RGD:1353398 6480464 [ATG5 protein affects the susceptibility to Paraquat] which affects the abundance of Lipofuscin more ... CTD PMID:22982048 more ... patulin multiple interactions ISO RGD:1353398 6480464 ATG5 protein affects the reaction [Patulin results in increased expression of and results in increased cleavage of GSDMD protein], ATG5 protein affects the reaction [Patulin results in increased expression of IL1B protein] CTD PMID:33217525 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of ATG5 mRNA CTD PMID:27825932 perfluorooctanoic acid increases expression ISO RGD:1556965 6480464 perfluorooctanoic acid results in increased expression of ATG5 mRNA CTD PMID:26879310 perfluorooctanoic acid multiple interactions ISO RGD:1353398 6480464 ATG5 protein promotes the reaction [perfluorooctanoic acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:26879310 phenobarbital multiple interactions EXP 6480464 Phenobarbital inhibits the reaction [Dietary Fats results in increased expression of ATG5 mRNA] CTD PMID:36657701 pirinixic acid increases expression ISO RGD:1556965 6480464 pirinixic acid results in increased expression of ATG5 mRNA CTD PMID:23811191 potassium chromate decreases expression ISO RGD:1353398 6480464 potassium chromate(VI) results in decreased expression of ATG5 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1353398 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATG5 mRNA CTD PMID:22079256 potassium dichromate multiple interactions EXP 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ATG5 protein CTD PMID:36849043 promethazine decreases expression ISO RGD:1353398 6480464 Promethazine results in decreased expression of ATG5 protein CTD PMID:31682805 propiconazole decreases expression ISO RGD:1556965 6480464 propiconazole results in decreased expression of ATG5 mRNA CTD PMID:21278054 pterostilbene multiple interactions ISO RGD:1556965 6480464 pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein], SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]] CTD PMID:34405320 pterostilbene multiple interactions ISO RGD:1353398 6480464 pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein], SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]] CTD PMID:34405320 pyrroloquinoline quinone multiple interactions ISO RGD:1353398 6480464 PQQ Cofactor inhibits the reaction [Doxorubicin results in increased expression of ATG5 protein] CTD PMID:31226464 quercetin multiple interactions ISO RGD:1353398 6480464 Quercetin results in increased expression of [ATG12 protein binds to ATG5 protein] CTD PMID:25293876 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of ATG5 mRNA] CTD PMID:34751495 rac-lactic acid decreases expression ISO RGD:1353398 6480464 Lactic Acid results in decreased expression of ATG5 mRNA CTD PMID:30851411 raloxifene multiple interactions ISO RGD:1353398 6480464 Raloxifene Hydrochloride promotes the reaction [ATG12 protein binds to ATG5 protein] CTD PMID:25537862 reactive oxygen species decreases abundance ISO RGD:1353398 6480464 ATG5 protein results in decreased abundance of Reactive Oxygen Species CTD PMID:31926197 resveratrol affects response to substance ISO RGD:1353398 6480464 ATG5 protein affects the susceptibility to resveratrol CTD PMID:23680031 resveratrol increases expression ISO RGD:1556965 6480464 resveratrol results in increased expression of ATG5 mRNA CTD PMID:24095927 resveratrol multiple interactions ISO RGD:1556965 6480464 resveratrol promotes the reaction [Ethanol results in increased expression of ATG5 mRNA] CTD PMID:24095927 resveratrol multiple interactions ISO RGD:1353398 6480464 ATG5 protein affects the reaction [[TNF protein co-treated with Resveratrol] results in increased expression of MAP1LC3B protein alternative form] more ... CTD PMID:23680031 more ... resveratrol increases expression ISO RGD:1353398 6480464 resveratrol results in increased expression of ATG5 mRNA CTD PMID:12002526 more ... rotenone multiple interactions ISO RGD:1353398 6480464 ATG5 protein affects the reaction [Sirolimus inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein]] more ... CTD PMID:19682553 more ... rotenone decreases expression ISO RGD:1353398 6480464 Rotenone results in decreased expression of ATG5 protein CTD PMID:30141137 , PMID:31926197 rotenone increases expression EXP 6480464 Rotenone results in increased expression of ATG5 protein CTD PMID:25725130 rotenone multiple interactions EXP 6480464 [Particulate Matter co-treated with Rotenone] results in decreased expression of ATG5 protein more ... CTD PMID:25725130 , PMID:33823232 rotenone affects response to substance ISO RGD:1353398 6480464 ATG5 protein affects the susceptibility to Rotenone CTD PMID:18032788 roxadustat multiple interactions EXP 6480464 roxadustat promotes the reaction [Hyaluronic Acid results in increased cleavage of ATG5 protein] CTD PMID:27082295 ruthenium red multiple interactions EXP 6480464 Ruthenium Red inhibits the reaction [Cadmium Compounds results in increased expression of ATG5 protein] CTD PMID:34308505 SB 203580 multiple interactions ISO RGD:1353398 6480464 SB 203580 inhibits the reaction [Calcitriol results in increased activity of ATG5 mRNA] CTD PMID:19748465 sevoflurane increases expression ISO RGD:1353398 6480464 Sevoflurane results in increased expression of ATG5 protein CTD PMID:35472370 silicon dioxide multiple interactions ISO RGD:1556965 6480464 GAS6 gene mutant form inhibits the reaction [Silicon Dioxide results in increased expression of ATG5 mRNA] more ... CTD PMID:33232774 silicon dioxide increases expression ISO RGD:1556965 6480464 Silicon Dioxide results in increased expression of ATG5 mRNA, Silicon Dioxide results in increased expression of ATG5 protein CTD PMID:33232774 sirolimus multiple interactions ISO RGD:1353398 6480464 [Sirolimus co-treated with TNF protein] results in increased expression of ATG5 mRNA more ... CTD PMID:19682553 more ... sirolimus multiple interactions ISO RGD:1556965 6480464 Sirolimus inhibits the reaction [OTUD7B protein inhibits the reaction [Doxorubicin results in increased expression of ATG5 protein]] CTD PMID:36639017 sirolimus increases expression ISO RGD:1353398 6480464 Sirolimus results in increased expression of ATG5 protein CTD PMID:29781141 , PMID:30338810 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of ATG5 mRNA, Sirolimus results in increased expression of ATG5 protein CTD PMID:30611790 sirolimus multiple interactions EXP 6480464 [Sirolimus co-treated with cadmium acetate] results in increased expression of ATG5 mRNA more ... CTD PMID:29128638 more ... sodium arsenite increases expression ISO RGD:1353398 6480464 sodium arsenite results in increased expression of ATG5 protein CTD PMID:28888487 sodium arsenite multiple interactions ISO RGD:1556965 6480464 [sodium arsenite co-treated with Dietary Fats] results in increased expression of ATG5 mRNA CTD PMID:30097599 sodium arsenite multiple interactions ISO RGD:1353398 6480464 ATG5 protein affects the reaction [sodium arsenite results in increased expression of BECN1 protein] CTD PMID:28888487 sodium fluoride increases expression ISO RGD:1556965 6480464 Sodium Fluoride results in increased expression of ATG5 mRNA, Sodium Fluoride results in increased expression of ATG5 protein CTD PMID:24296261 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of ATG5 mRNA, Sodium Fluoride results in increased expression of ATG5 protein CTD PMID:24296261 Soman increases expression EXP 6480464 Soman results in increased expression of ATG5 protein CTD PMID:31102696 sorafenib multiple interactions ISO RGD:1353398 6480464 [Sorafenib co-treated with Vorinostat] promotes the reaction [FAS protein binds to CASP8 protein binds to ATG5 protein binds to HSPA5 protein] more ... CTD PMID:18787411 sorafenib increases expression ISO RGD:1353398 6480464 sorafenib results in increased expression of ATG5 protein CTD PMID:18787411 stilbenoid decreases response to substance ISO RGD:1353398 6480464 ATG5 protein results in decreased susceptibility to Stilbenes CTD PMID:23059970 streptozocin increases expression ISO RGD:1556965 6480464 Streptozocin results in increased expression of ATG5 mRNA CTD PMID:24889822 streptozocin multiple interactions EXP 6480464 [[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of ATG5 mRNA, [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of ATG5 mRNA CTD PMID:35786680 swainsonine multiple interactions ISO RGD:1556965 6480464 [bafilomycin A1 co-treated with Swainsonine] results in increased expression of ATG5 mRNA, [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of ATG5 protein CTD PMID:36402259 swainsonine increases expression ISO RGD:1556965 6480464 Swainsonine results in increased expression of ATG5 mRNA, Swainsonine results in increased expression of ATG5 protein CTD PMID:36402259 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of ATG5 protein CTD PMID:29413859 T-2 toxin increases expression ISO RGD:1556965 6480464 T-2 Toxin results in increased expression of ATG5 protein CTD PMID:35289972 T-2 toxin affects expression ISO RGD:1556965 6480464 T-2 Toxin affects the expression of ATG5 protein CTD PMID:36402210 T-2 toxin multiple interactions ISO RGD:1556965 6480464 3-methyladenine affects the reaction [T-2 Toxin affects the expression of ATG5 protein] CTD PMID:36402210 temozolomide decreases expression ISO RGD:1353398 6480464 Temozolomide results in decreased expression of ATG5 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO RGD:1353398 6480464 tert-Butylhydroperoxide results in decreased expression of ATG5 mRNA CTD PMID:15336504 tetrachloromethane multiple interactions ISO RGD:1556965 6480464 [TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of ATG5 protein more ... CTD PMID:31513885 , PMID:33549628 thymoquinone decreases expression ISO RGD:1353398 6480464 thymoquinone results in decreased expression of ATG5 protein CTD PMID:31298468 trans-piceid multiple interactions ISO RGD:1353398 6480464 polydatin inhibits the reaction [Rotenone results in decreased expression of ATG5 protein] CTD PMID:31926197 Triptolide increases expression ISO RGD:1556965 6480464 triptolide results in increased expression of ATG5 protein CTD PMID:26990902 trovafloxacin affects response to substance ISO RGD:1353398 6480464 ATG5 protein affects the susceptibility to trovafloxacin CTD PMID:33609687 trovafloxacin increases expression ISO RGD:1353398 6480464 trovafloxacin results in increased expression of ATG5 mRNA CTD PMID:33609687 trovafloxacin multiple interactions ISO RGD:1353398 6480464 ATG5 protein affects the reaction [trovafloxacin results in increased cleavage of CASP3 protein] more ... CTD PMID:33609687 tunicamycin multiple interactions ISO RGD:1353398 6480464 Curcumin inhibits the reaction [Tunicamycin results in increased expression of ATG5 protein] CTD PMID:36640941 tunicamycin increases expression ISO RGD:1556965 6480464 Tunicamycin results in increased expression of ATG5 mRNA CTD PMID:29793971 tunicamycin increases response to substance ISO RGD:1556965 6480464 ATG5 protein mutant form results in increased susceptibility to Tunicamycin CTD PMID:29793971 tunicamycin multiple interactions ISO RGD:1556965 6480464 [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of ATF4 mRNA more ... CTD PMID:29793971 tunicamycin increases expression ISO RGD:1353398 6480464 Tunicamycin results in increased expression of ATG5 protein CTD PMID:36640941 valproic acid increases expression ISO RGD:1353398 6480464 Valproic Acid results in increased expression of ATG5 mRNA CTD PMID:23527032 valproic acid decreases expression ISO RGD:1353398 6480464 Valproic Acid results in decreased expression of ATG5 mRNA CTD PMID:27188386 valproic acid affects expression ISO RGD:1353398 6480464 Valproic Acid affects the expression of ATG5 mRNA CTD PMID:23179753 vorinostat multiple interactions ISO RGD:1353398 6480464 [sorafenib co-treated with vorinostat] promotes the reaction [FAS protein binds to CASP8 protein binds to ATG5 protein binds to HSPA5 protein] more ... CTD PMID:18787411 , PMID:20543569 vorinostat increases expression ISO RGD:1353398 6480464 vorinostat results in increased expression of ATG5 mRNA CTD PMID:27188386 zearalenone increases expression ISO RGD:1556965 6480464 Zearalenone results in increased expression of ATG5 mRNA, Zearalenone results in increased expression of ATG5 protein CTD PMID:34537261 zinc atom multiple interactions ISO RGD:1353398 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ATG5 mRNA CTD PMID:18593933 zinc oxide increases expression ISO RGD:1556965 6480464 Zinc Oxide analog results in increased expression of ATG5 mRNA CTD PMID:24614525 zinc oxide increases expression EXP 6480464 Zinc Oxide results in increased expression of ATG5 mRNA CTD PMID:32951350 zinc oxide multiple interactions ISO RGD:1556965 6480464 Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of ATG5 mRNA] CTD PMID:24614525 zinc(0) multiple interactions ISO RGD:1353398 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ATG5 mRNA CTD PMID:18593933
